Related Experiment Video
Updated: Oct 23, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.1K
Utilizing CGM Ambulatory Glucose Profiles to Optimize Diabetes Management
The Journal of Family Practice
|August 25, 2021
Summary
This activity teaches healthcare professionals to use continuous glucose monitoring (CGM) data. Learn to identify suitable patients and interpret ambulatory glucose profiles (AGP) for improved diabetes management.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Diabetes Management
Background:
- Traditional blood glucose monitoring has limitations in providing comprehensive glycemic insights.
- Continuous Glucose Monitoring (CGM) offers dynamic glucose data, enabling a more nuanced understanding of glycemic control.
- Effective interpretation and application of CGM data are crucial for optimizing patient care.
Purpose of the Study:
- To equip participants with the knowledge to differentiate between patients who would benefit from CGM versus traditional fingerstick monitoring.
- To educate on the diverse data types generated by CGM systems.
- To enable the interpretation of CGM data, specifically using the Ambulatory Glucose Profile (AGP), against established Time in Range targets.
- To empower participants to adjust treatment plans based on CGM insights, ultimately improving patient outcomes.
Main Methods:
- Didactic presentation of CGM technology and data interpretation principles.
- Case-based discussions on patient selection for CGM.
- Training on utilizing the Ambulatory Glucose Profile (AGP) for glycemic assessment.
- Interactive sessions on modifying treatment strategies based on CGM-derived information.
Main Results:
- Participants will be able to identify appropriate candidates for CGM.
- Participants will gain proficiency in understanding the information provided by CGM systems.
- Participants will be able to interpret AGP reports to assess Time in Range.
- Participants will be able to apply CGM data to personalize and optimize diabetes treatment plans.
Conclusions:
- Continuous Glucose Monitoring (CGM) provides valuable data for diabetes management.
- Interpreting CGM data, particularly AGP, is essential for achieving glycemic targets.
- Application of CGM insights facilitates personalized treatment adjustments and improved patient outcomes.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
585
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
585
Diabetes Mellitus: Type 2 and Gestational
3.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.5K
Hypoglycemia and Glucagon
471
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
471
Diabetes Mellitus: Overview and Type I Subtype
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.9K
Diabetes: Symptoms, Diagnosis, and Complications
1.3K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.3K
Hormones Regulating Blood Glucose
5.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
5.0K

